D-0654-2020 Class I Terminated
FDA drug recall D-0654-2020 was initiated by Motto International Corp on Dec 17, 2019 and is designated Class I. Reason for recall: Marketed without an Approved NDA/ANDA; FDA analysis found product to contain tadalfil The recall status is terminated (terminated Oct 29, 2021). Affected quantity: 8 boxes.
Recall details
- Product Type
- Drugs
- Report Date
- Jan 22, 2020
- Initiation Date
- Dec 17, 2019
- Termination Date
- Oct 29, 2021
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 8 boxes
Product description
Bull Platinum 30000 Capsules, 1000 mg, in orange, white, yellow background with silver text, packaged in 2, 4 and 10 count blister cards, Motto International, Dallas, TX
Reason for recall
Marketed without an Approved NDA/ANDA; FDA analysis found product to contain tadalfil
Distribution pattern
TX
Code information
All lots remaining within expiry.
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0654-2020
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026